Cizzle Biotechnology (LON:CIZ) Stock Price Down 6.4% – What’s Next?

Cizzle Biotechnology Holdings Plc (LON:CIZ) shares fell 6.4% on Monday . The stock traded as low as GBX 2.91 and last traded at GBX 2.91. 182,832 shares were traded during trading, a decline of 84% from the average session volume of 1,165,047 shares. The stock had previously closed at GBX 3.11.

Cizzle Biotechnology Stock Down 2.7%

The business has a fifty day moving average of GBX 2.66 and a 200 day moving average of GBX 1.98. The company has a market cap of £12.41 million, a P/E ratio of -17.18 and a beta of 0.07.

Cizzle Biotechnology (LON:CIZ) last released its quarterly earnings data on Tuesday, May 5th. The company reported GBX (0.17) EPS for the quarter.

About Cizzle Biotechnology

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.